NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NICHD E-155-1999-0-ES-37 17-Alpha-Substituted 11-Beta-Substituted-4-Aryl and 21-Substituted 19-Norpregnadienedione as Antiprogestational Agents ES EP 10010646.7 Abandoned
NICHD E-155-1999-0-IT-40 17-Alpha-Substituted 11-Beta-Substituted-4-Aryl and 21-Substituted 19-Norpregnadienedione as Antiprogestational Agents IT EP 10010646.7 Abandoned
NICHD E-155-1999-0-IT-50 17-Alpha-Substituted 11-Beta-Substituted-4-Aryl and 21-Substituted 19-Norpregnadienedione as Antiprogestational Agents IT EP 10010647.5 Abandoned
NICHD E-155-1999-0-NL-51 17-Alpha-Substituted 11-Beta-Substituted-4-Aryl and 21-Substituted 19-Norpregnadienedione as Antiprogestational Agents NL EP 10010647.5 Abandoned
NICHD E-155-1999-0-SE-52 17-Alpha-Substituted 11-Beta-Substituted-4-Aryl and 21-Substituted 19-Norpregnadienedione as Antiprogestational Agents SE EP 10010647.5 Abandoned
NICHD E-155-1999-0-ES-47 17-Alpha-Substituted 11-Beta-Substituted-4-Aryl and 21-Substituted 19-Norpregnadienedione as Antiprogestational Agents ES EP 10010647.5 Abandoned
NICHD E-155-1999-0-GB-49 17-Alpha-Substituted 11-Beta-Substituted-4-Aryl and 21-Substituted 19-Norpregnadienedione as Antiprogestational Agents GB EP 10010647.5 Abandoned
NICHD E-155-1999-0-CH-45 17-Alpha-Substituted 11-Beta-Substituted-4-Aryl and 21-Substituted 19-Norpregnadienedione as Antiprogestational Agents CH EP 10010647.5 Abandoned
NICHD E-155-1999-0-AT-43 17-Alpha-Substituted 11-Beta-Substituted-4-Aryl and 21-Substituted 19-Norpregnadienedione as Antiprogestational Agents AT EP 10010647.5 Abandoned
NICHD E-155-1999-0-BE-44 17-Alpha-Substituted 11-Beta-Substituted-4-Aryl and 21-Substituted 19-Norpregnadienedione as Antiprogestational Agents BE EP 10010647.5 Abandoned
NICHD E-155-1999-0-DE-46 17-Alpha-Substituted 11-Beta-Substituted-4-Aryl and 21-Substituted 19-Norpregnadienedione as Antiprogestational Agents DE EP 10010647.5 Abandoned
NICHD E-155-1999-0-FR-48 17-Alpha-Substituted 11-Beta-Substituted-4-Aryl and 21-Substituted 19-Norpregnadienedione as Antiprogestational Agents FR EP 10010647.5 Abandoned
NICHD E-155-1999-0-EP-29 17-Alpha-Substituted 11-Beta-Substituted-4-Aryl and 21-Substituted 19-Norpregnadienedione as Antiprogestational Agents EP DIV 10010647.5 Abandoned
NICHD E-155-1999-0-JP-06 STRUCTURAL MODIFICATION OF 19-NORPROGESTERONE I: 17-a-SUBSTITUTED-11-B-SUBSTITUTED-4-ARYL AND 21-SUBSTITUTED 19-NORPREGNADIENEDIONE AS NEW ANTIPROGESTATIONAL AGENTS JP National Stage 2001-572529 Abandoned
NICHD E-155-1999-0-CA-04 17-ALPHA-SUBSTITUTED-11-BETA-SUBSTITUTED-4-ARYL AND 21-SUBSTITUTED 19-NORPREGNA 21-SUBSTITUTED 19-NORPREGNADIENEDIONE AS ANTIPROGESTATIONAL AGENTS CA National Stage 2403756 Abandoned
NICHD E-155-1999-0-DK-23 17-Alpha-Substituted 11-Beta-4-Substituted-Aryl and 21-Substituted 19 Norpregnadienedione as New Antiprogestational DK EP 01918812.7 Abandoned
NICHD E-155-1999-0-CY-11 17-Alpha-Substituted 11-Beta-4-Substituted-Aryl and 21-Substituted 19 Norpregnadienedione as New Antiprogestational CY EP 01918812.7 Abandoned
NICHD E-155-1999-0-LU-26 17-Alpha-Substituted 11-Beta-4-Substituted-Aryl and 21-Substituted 19 Norpregnadienedione as New Antiprogestational LU EP 01918812.7 Abandoned
NICHD E-155-1999-0-GR-17 17-Alpha-Substituted 11-Beta-4-Substituted-Aryl and 21-Substituted 19 Norpregnadienedione as New Antiprogestational GR EP 01918812.7 Abandoned
NICHD E-155-1999-0-IE-24 17-Alpha-Substituted 11-Beta-4-Substituted-Aryl and 21-Substituted 19 Norpregnadienedione as New Antiprogestational IE EP 01918812.7 Abandoned
NICHD E-155-1999-0-IT-25 17-Alpha-Substituted 11-Beta-4-Substituted-Aryl and 21-Substituted 19 Norpregnadienedione as New Antiprogestational IT EP 01918812.7 Abandoned
NICHD E-155-1999-0-FR-15 17-Alpha-Substituted 11-Beta-4-Substituted-Aryl and 21-Substituted 19 Norpregnadienedione as New Antiprogestational FR EP 01918812.7 Abandoned
NICHD E-155-1999-0-DE-12 17-Alpha-Substituted 11-Beta-4-Substituted-Aryl and 21-Substituted 19 Norpregnadienedione as New Antiprogestational DE EP 01918812.7 Abandoned
NICHD E-155-1999-0-FI-14 17-Alpha-Substituted 11-Beta-4-Substituted-Aryl and 21-Substituted 19 Norpregnadienedione as New Antiprogestational FI EP 01918812.7 Abandoned
NICHD E-155-1999-0-AT-08 17-Alpha-Substituted 11-Beta-4-Substituted-Aryl and 21-Substituted 19 Norpregnadienedione as New Antiprogestational AT EP 01918812.7 Abandoned
NICHD E-155-1999-0-BE-09 17-Alpha-Substituted 11-Beta-4-Substituted-Aryl and 21-Substituted 19 Norpregnadienedione as New Antiprogestational BE EP 01918812.7 Abandoned
NICHD E-155-1999-0-MC-18 17-Alpha-Substituted 11-Beta-4-Substituted-Aryl and 21-Substituted 19 Norpregnadienedione as New Antiprogestational MC EP 01918812.7 Abandoned
NICHD E-155-1999-0-ES-13 17-Alpha-Substituted 11-Beta-4-Substituted-Aryl and 21-Substituted 19 Norpregnadienedione as New Antiprogestational ES EP 01918812.7 Abandoned
NICHD E-155-1999-0-NL-19 17-Alpha-Substituted 11-Beta-4-Substituted-Aryl and 21-Substituted 19 Norpregnadienedione as New Antiprogestational NL EP 01918812.7 Abandoned
NICHD E-155-1999-0-PT-20 17-Alpha-Substituted 11-Beta-4-Substituted-Aryl and 21-Substituted 19 Norpregnadienedione as New Antiprogestational PT EP 01918812.7 Abandoned
NICHD E-155-1999-0-TR-22 17-Alpha-Substituted 11-Beta-4-Substituted-Aryl and 21-Substituted 19 Norpregnadienedione as New Antiprogestational TR EP 01918812.7 Abandoned
NICHD E-155-1999-0-CH-10 17-Alpha-Substituted 11-Beta-4-Substituted-Aryl and 21-Substituted 19 Norpregnadienedione as New Antiprogestational CH EP 01918812.7 Abandoned
NICHD E-155-1999-0-SE-21 17-Alpha-Substituted 11-Beta-4-Substituted-Aryl and 21-Substituted 19 Norpregnadienedione as New Antiprogestational Agents SE EP 01918812.7 Abandoned
NICHD E-155-1999-0-GB-16 17-Alpha-Substituted 11-Beta-4-Substituted-Aryl and 21-Substituted 19 Norpregnadienedione as New Antiprogestational GB EP 01918812.7 Abandoned
NICHD E-155-1999-0-EP-05 17-Alpha-Substituted 11-Beta-Substituted-4-Aryl and 21-Substituted 19-Norpregnadienedione as New Antiprogestational Agents EP National Stage 01918812.7 Abandoned
NIMH E-059-1998-0-US-02 Use of Immunotoxins to Induce Immune Tolerance to Pancreatic Islet Transplantation US CON 09/810,999 7288254 Expired PDF
NICHD E-155-1999-0-AU-03 Structural Modification of 19-Norpregnadienedione I: 17-a-Alpha-Substituted-11-Beta-4-Aryl and 21-Substituted 19-Norpregnadienedione as New Antiprogestational Agents AU National Stage 2001245849 Abandoned
NIDDK E-163-1991-2-US-02 A Method for Reducing the Immunogenicity of Antibody Variable Domains US CON 09/810,502 6797492 Expired PDF
NINDS E-235-1998-0-US-03 CELL EXPANSION SYSTEM FOR USE IN NEURAL TRANSPLANTATION US National Stage 09/744,384 6787356 Expired PDF
NICHD E-155-1999-0-PCT-02 Structural Modification of19-Norprogesterone I: 17-a-Substituted,11-alpha-Substituted-4Aryl and 21-Substituted 19-Norpregnadienedione As New Antiprogestational Agents PCT PCT PCT/US01/08681 Expired
NICHD E-155-1999-0-EP-27 17-Alpha-Substituted 11-Beta-4-Substituted-Aryl and 21-Substituted 19 Norpregnadienedione as Antiprogestational Agents EP DIV 08009259.6 Abandoned
NCI E-196-1992-3-JP-07 BIOPOLYMER-BOUND NITRIC OXIDE/NUCLEOPHILE ADDUCT COMPOSITIONS, PHARMACEUTICAL COMPOSITIONS INCORPORATING SAME AND METHODS OF.... JP National Stage 2001-076404 Abandoned
NEI E-241-1999-0-US-01 Ocular Therapeutic Agent Delivery Devices And Methods For Making And Using Such Devices US ORD 09/808,149 6713081 Expired PDF
NCI E-197-2000-0-PCT-02 Transfer Microdissection PCT PCT PCT/US2001/008095 Expired
NCI E-197-2000-0-EP-05 Transfer Microdissection EP National Stage 01918647.7 Abandoned
NINDS E-012-2000-0-US-01 Postsynaptic Response By Increasing Intracellular Calcium US 60/275,463 Abandoned
NCI E-128-2000-0-US-02 Methods and Compositions For Co-Stimulation Of Immunological Responses To Peptide Antigens US ORD 09/810,310 Abandoned
NCI E-197-2000-0-CA-04 Transfer Microdissection CA National Stage 2415864 Abandoned
NCI E-323-2000-0-US-01 Activated Dual Specificity T Lymphocytes and Their Methods of Use US ORD 09/803,578 7723111 Abandoned PDF
NCI E-321-2000-0-US-01 Antisense Oligonucleotides Targeting Folate Receptor Alpha, And the Use Thereof US 60/274,249 Abandoned